These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6850652)

  • 1. Hypermetabolism of phenytoin as a cause of treatment failure.
    Lebrun LH; Villeneuve JP
    Clin Neuropharmacol; 1983 Mar; 6(1):67-70. PubMed ID: 6850652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of phenytoin parahydroxylation as a cause of severe intoxication.
    de Wolff FA; Vermeij P; Ferrari MD; Buruma OJ; Breimer DD
    Ther Drug Monit; 1983 Jun; 5(2):213-5. PubMed ID: 6879646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiopyrine half-life as a measure of hepatic enzyme induction: clinical applications in a chronic epileptic population.
    Byrne E; Harman AW; Frewin DB; Hallpike JF
    Clin Exp Neurol; 1979; 16():183-9. PubMed ID: 550940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phenytoin metabolism by other drugs used in epilepsy.
    Houghton GW; Richens A
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):210-6. PubMed ID: 240782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and pharmacokinetics of phenytoin during pregnancy.
    Lander CM; Smith MT; Chalk JB; de Wytt C; Symoniw P; Livingstone I; Eadie MJ
    Eur J Clin Pharmacol; 1984; 27(1):105-10. PubMed ID: 6489420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent Michaelis-Menten kinetic parameters of phenytoin in pediatric patients.
    Chiba K; Ishizaki T; Miura H; Minagawa K
    Pediatr Pharmacol (New York); 1980; 1(2):171-80. PubMed ID: 7346739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin and phenobarbitone plasma level-dose relationships in Chinese epileptic children in Singapore.
    Lee HS; Chan KY
    Ther Drug Monit; 1981; 3(3):247-52. PubMed ID: 7324089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin-diazepam interaction.
    Murphy A; Wilbur K
    Ann Pharmacother; 2003 May; 37(5):659-63. PubMed ID: 12708941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G; Brand N; MacLeod SM
    Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of phenytoin.
    Richens A
    Clin Pharmacokinet; 1979; 4(3):153-69. PubMed ID: 383353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profound reduction in the tamoxifen active metabolite endoxifen in a patient on phenytoin for epilepsy compared with a CYP2D6 genotype matched cohort.
    Gryn SE; Teft WA; Kim RB
    Pharmacogenet Genomics; 2014 Jul; 24(7):367-9. PubMed ID: 24915025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative estimation of catechol/methylcatechol pathways in human phenytoin metabolism.
    Maguire JH
    Epilepsia; 1988; 29(6):753-9. PubMed ID: 3191891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
    Ebid AH; Ahmed MM; Mohammed SA
    Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenytoin metabolism in pregnancy.
    Kochenour NK; Emery MG; Sawchuk RJ
    Obstet Gynecol; 1980 Nov; 56(5):577-82. PubMed ID: 7432728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic testing of medical intractability for carbamazepine, phenytoin, and phenobarbital or primidone in monotherapy for patients considered for epilepsy surgery.
    Hermanns G; Noachtar S; Tuxhorn I; Holthausen H; Ebner A; Wolf P
    Epilepsia; 1996 Jul; 37(7):675-9. PubMed ID: 8681900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary phenytoin concentrations in epilepsy and in chronic renal failure.
    Reynolds F; Ziroyanis PN; Jones NF; Smith SE
    Lancet; 1976 Aug; 2(7982):384-6. PubMed ID: 73850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the bioavailability of Polfa phenytoin tablets].
    Lazowski J; Lypka A; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin therapy for epileptic children: evaluation of salivary and plasma concentrations and of methods of assessing compliance.
    Zysset T; Rüdeberg A; Vassella F; Küpfer A; Bircher J
    Dev Med Child Neurol; 1981 Feb; 23(1):66-75. PubMed ID: 6781961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pregnancy on antiepileptic drug utilization.
    Levy RH; Yerby MS
    Epilepsia; 1985; 26 Suppl 1():S52-7. PubMed ID: 3922750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin and folic acid: individualized drug-drug interaction.
    Berg MJ; Rivey MP; Vern BA; Fischer LJ; Schottelius DD
    Ther Drug Monit; 1983; 5(4):395-9. PubMed ID: 6659013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.